Nutra Pharma Corporation, a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), human immunodeficiency virus (HIV), multiple sclerosis (MS) and pain, announced that it has selected Amarey Nova Medical S.A. to serve as the exclusive distributor in Colombia for its Nyloxin-branded pain relievers.

"We are excited to be working with Amarey Nova Medical to introduce Nyloxin throughout the Colombian healthcare market," explained Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. "As one of the leading pharmaceutical distributors in Colombia, Amarey brings the expertise and ability to support the growth of new healthcare products such as Nyloxin throughout Colombia," he added.

Amarey Nova Medical S.A., which offers over 23 years of experience in the Colombian pharmaceutical market, provides 100 per cent sales coverage throughout Colombia. The company's sales force is located in Bogota, Cali, Medellin, Barranquilla, Bucaramanga, Cucuta, and Pereira. Companies, whose products are represented by Amarey, include Eli Lilly, Pfizer, Stryker, Merck Novo Nordisk, and Roche.